„A strong start into the year 2026, driven by a combination of organic growth and targeted acquisitions in our DACH-region“ – Dr. Stefan Niemeier, Dr. Nils Schlag, Co-CEOs

Q1 2026 net sales rose 61% year over year to EUR 21.705 million, with organic growth of 17%, while EBITA increased 64% to EUR 3.879 million and the EBITA margin improved to 18% from 15%. Operating profit climbed 73% to EUR 2.724 million, and EPS was EUR 0.03. The period also included consolidation of Brainware Solutions GmbH and the listing of ARENIT Industrie SE SDRs on NASDAQ First North Premier Growth Market on March 17, 2026.

Analysis

This print suggests the company is moving from “small-cap story” to “platform compounding” mode: the revenue mix is now likely being driven more by bolt-on contribution and cross-sell than by pure end-market growth. The second-order implication is that integration quality, not demand, becomes the main determinant of margin durability over the next 2-3 quarters; if the acquired business carries even modestly lower gross margin, the current EBITA profile could flatten before synergies are fully realized.

The listing on Nasdaq First North Premier also changes the capital-allocation playbook. Public-market currency should improve acquisition optionality, but it also raises the bar on disclosure, free float quality, and quarterly execution; that combination often creates a near-term “good news, then prove it” setup where the first post-listing quarter is strongest and subsequent reactions depend on whether organic growth re-accelerates. The market will likely reward continued high-teens organic growth more than headline growth, because acquisition-led prints are easier to discount once the equity has rerated.

The main risk is that the current growth rate may be artificially boosted by one or two integration events and by timing effects in customer procurement, which can reverse over the next 1-2 quarters. If the new subsidiary was acquired using equity or debt, hidden dilution and leverage drift could start to matter as investors move from topline to per-share economics. The contrarian view is that the share listing itself may be a catalyst for multiple expansion, but only if management can show repeatable M&A with no margin bleed; otherwise the market may treat this as a one-off re-rating rather than a sustained growth story.

Key Decisions for Investors

• Long the newly listed shares on weakness over the next 1-3 weeks, but size modestly; the setup favors a post-listing momentum trade with 10-15% upside if the market rewards the first clean quarter as a public company.
• Trim or fade rallies if the stock gaps up >8-10% on the print: the risk/reward shifts quickly if investors begin pricing in acquisition-driven growth without evidence of durable organic acceleration.
• If liquidity is sufficient, consider a 3-6 month call spread to express continued re-rating potential while capping downside from integration misses; use strikes around a 15-20% upside scenario versus current levels.
• Watch for any disclosed leverage or earn-out structure tied to the new acquisition; if debt-funded, reduce exposure on signs of margin compression or covenant sensitivity over the next 2 quarters.
• Relative-value idea: long the company versus a more mature Nordic small-cap IT/services peer basket if organic growth stays above mid-teens; the spread should outperform if market rewards M&A optionality and listing-driven attention.